GlassScriptPhysician profile
Frank Iannetta
NPI 1881621217
$5,850.90
in general payments reported to CMS, 2019-2025
42 companies · $958 in 2025
The $958 reported for 2025 was more than what 85% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $654 · 2020: $490 · 2021: $791 · 2022: $1,078 · 2023: $1,001 · 2024: $879 · 2025: $958.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,838.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,837.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,173.80 | 2021-2025 | |
| Novo Nordisk INC | $609.31 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Amgen INC. | $542.14 | 2019-2025 | Otezla, Repatha, Otezla |
| Pfizer INC. | $534.62 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $516.48 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Glaxosmithkline, LLC. | $291.65 | 2019-2025 | Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $281.24 | 2019-2025 | Jardiance, Synjardy, Spiriva Respimat |
| Lilly USA, LLC | $252.30 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Exact Sciences Corporation | $178.44 | 2023-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $141.73 | 2019-2025 | Breztri, Farxiga |
| Allergan, INC. | $126.87 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $125.88 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $120.29 | 2024 | |
| Janssen Pharmaceuticals, INC | $107.76 | 2019-2025 | Spravato |
| Kowa Pharmaceuticals America, INC. | $99.70 | 2020-2025 | Zoryve |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Iannetta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.